Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.
about
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsCurrent prospects for the fluoroquinolones as first-line tuberculosis therapyGenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsEvaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic reviewRapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysisFirst evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrAMolecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosisClofazimine: current status and future prospects.Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system.Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections.GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.Evaluation of the BACTEC MGIT 960 SL DST Kit and the GenoType MTBDRsl Test for Detecting Extensively Drug-resistant Tuberculosis Cases.Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China.Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.Association of gyrA and rrs gene mutations detected by MTBDRsl V1 on Mycobacterium tuberculosis strains of diverse genetic background from India.
P2860
Q24193002-5FFC6277-FCF2-402C-9EB9-49F2303D51C1Q26823843-B96C7C24-F50B-461E-A4CE-8928318CFDFEQ28068545-56D7821B-C378-453B-9E4B-C68EFB4CD8B9Q28481845-F1947FCE-94CC-4F6D-B73C-A81275FF4684Q28485912-890A9AE8-5784-4E44-876F-1EB672B7D503Q28538008-22E7C03D-4727-454A-841D-D572B0D1BE43Q34483621-0B909262-EDEF-4F27-970A-1FB89C6AA616Q34633213-6380770B-E731-4761-9393-2B1434F58F01Q34933405-C1125B3B-92B3-431F-BD9E-457AA739986CQ35270379-F48ED2F4-D4A8-4488-948E-89FA4316A965Q35850402-57699FF2-30E6-40BC-9223-4CE4FB79C3BFQ35960685-E3F36E45-1611-489F-BC09-1A14AC58DEC5Q36290565-387EE1BB-8451-4E1F-BF3F-641E793545E3Q36773017-30CC4792-B109-4965-961B-01FC914FBF6BQ36794791-DEBA3953-E890-4162-9121-460DB1B89FEAQ36917933-B71BAC99-85F9-4726-BE0C-1855CC1FE91DQ38094353-06D2ED65-1011-4815-A36F-010BEACF47A4Q39079472-EC2E3893-EBA2-46BB-8E47-A1415A7F7B68Q39398946-C423CB2A-4656-4E31-A966-E8A9D8210F0CQ40280093-BE0D6F8F-567A-4352-BB91-C41359970F55Q40349308-3B141D88-A2D7-40FF-842C-E68D6B08207AQ44758479-EA84A566-28FB-46EA-B64F-B716F4489A8BQ45198957-40CE32B3-6677-46E5-92CE-139F5A12427AQ47139155-0A2E4AA8-BBB9-43DD-AD75-12419B30E3DBQ50788130-1EA3AEF9-474F-4806-9ECA-5CBF4B6174B0Q55346637-5E4D8799-AB46-43A5-BFAA-CB103404D45A
P2860
Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparative study on genotypic ...... tuberculosis complex isolates.
@ast
Comparative study on genotypic ...... tuberculosis complex isolates.
@en
Comparative study on genotypic ...... tuberculosis complex isolates.
@nl
type
label
Comparative study on genotypic ...... tuberculosis complex isolates.
@ast
Comparative study on genotypic ...... tuberculosis complex isolates.
@en
Comparative study on genotypic ...... tuberculosis complex isolates.
@nl
prefLabel
Comparative study on genotypic ...... tuberculosis complex isolates.
@ast
Comparative study on genotypic ...... tuberculosis complex isolates.
@en
Comparative study on genotypic ...... tuberculosis complex isolates.
@nl
P2093
P2860
P356
P1476
Comparative study on genotypic ...... tuberculosis complex isolates.
@en
P2093
Martin J Boeree
Miranda Kamst-van Agterveld
Rina de Zwaan
Sami Simons
Tridia van der Laan
P2860
P304
P356
10.1128/JCM.00652-10
P407
P577
2010-06-16T00:00:00Z